O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...
Jenscare Scientific’s Hong Kong IPO
Onewo’s US$738 Million Hong Kong IPO
Paul Hastings and JunHe advised Onewo Inc. on the deal. Herbert Smith Freehills advised CITIC Securities, Citigroup and Goldman Sachs as joint sponsors. Onewo Inc. announced its approximately...
Biocytogen Pharmaceuticals’ Listing on the Main Board of the Hong Kong Stock Exchange
Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and underwriters. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced the company’s official listing...
Linmon Media Limited’s HK$420 Million Initial Public Offering
Harneys acted as Cayman Islands counsel to Linmon Media Limited on the matter. Clifford Chance provided Hong Kong and US legal advice and CM Law Firm...
Rainmed Medical’s HK$146 Million IPO and Listing on the Hong Kong Stock Exchange
O’Melveny and Grandall represented Rainmed Medical Limited (2297.HK) on the deal. Herbert Smith Freehills has advised Huatai Financial Holdings. Rainmed Medical Limited (2297.HK) announced its US$19...
Yunkang Group Limited’s $140 Million Hong Kong Listing
Kirkland & Ellis and Zhong Lun advised Yunkang Group Limited on the deal. Herbert Smith Freehills advised CMB International Capital Limited and SPDB International Capital Limited....
Zhongyuan Bank Co., Ltd.’s HK$5,670 Million Placement
Herbert Smith Freehills has advised the placing agents and joint global coordinators. Huatai Financial Holdings (Hong Kong) Limited, CLSA Limited, China Securities (International) Corporate Finance Company...
Lepu Biopharma’s US$116.1 Million Hong Kong IPO and Listing
Clifford Chance has advised Lepu Biopharma Co., Ltd. on the deal. Herbert Smith Freehills has advised CICC and Morgan Stanley. The Joint Sponsors are CICC and...
Bio-heart Biological Technology Co. Ltd.’s Listing on the Stock Exchange of Hong Kong
Herbert Smith Freehills has advised Huatai Financial Holdings (Hong Kong) Limited. O’Melveny & Myers represented Bio-heart on the deal. Huatai Financial Holdings (Hong Kong) Limited acted...
Hangzhou SF Intra-city Industrial Co., Ld.’s Mainboard Listing on the Hong Kong Stock Exchange
Herbert Smith Freehills advised the joint sponsors involved in the IPO. Clifford Chance advised SF Intra-City Industrial Co. Ltd. SF Intra-city operates China’s largest third-party on-demand...
Seven Group Holdings Limited’s A$500 Million Underwritten Institutional Placement
Herbert Smith Freehills worked with Seven Group Holdings Limited on the deal. The deal involved a successful A$500 million fully underwritten institutional placement (Placement) and non-underwritten share...
Netjoy Holdings Limited’s HK$1.396 Billion Initial Public Offering
Herbert Smith Freehills has advised Haitong International on the deal, while Harneys, DeHeng and Tian Yuan Hong Kong acted as legal counsels to Netjoy Holdings Limited....